---
title: "Astrazeneca's KOSELUGO for the treatment of children aged 1 year and older has received FDA approval"
description: "Astrazeneca's KOSELUGO for the treatment of children aged 1 year and older has received FDA approval"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256770729.md"
published_at: "2025-09-10T13:55:01.000Z"
---

# Astrazeneca's KOSELUGO for the treatment of children aged 1 year and older has received FDA approval

Astrazeneca's KOSELUGO for the treatment of children aged 1 year and older has been approved by the FDA

### Related Stocks

- [AZN.US - AstraZeneca](https://longbridge.com/en/quote/AZN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| AstraZeneca Says US FDA Approves Calquence Combo for Certain Blood Cancer Patients | AstraZeneca Says US FDA Approves Calquence Combo for Certain Blood Cancer Patients | [Link](https://longbridge.com/en/news/276444179.md) |
| AstraZeneca PLC $AZN Shares Sold by Ontario Teachers Pension Plan Board | Ontario Teachers Pension Plan Board reduced its stake in AstraZeneca PLC (NASDAQ:AZN) by 41% in Q3, now holding 817,880  | [Link](https://longbridge.com/en/news/276339476.md) |
| Is It Time To Reopen The Franklin Child Prostitution Case After Epstein Revelations? | The article discusses the potential reopening of the Franklin Child Prostitution Case in light of new revelations from t | [Link](https://longbridge.com/en/news/276503065.md) |
| New Mexico Health Department: New Mexico Legislature Passed Bill Securing State's Ability to Purchase Childhood Vaccines | New Mexico Health Department: New Mexico Legislature Passed Bill Securing State's Ability to Purchase Childhood Vaccines | [Link](https://longbridge.com/en/news/276370732.md) |
| ZAWYA-PRESSR: ECA and Hub71 open applications for Anjal Z to accelerate global early childhood innovation in Abu Dhabi | The Abu Dhabi Early Childhood Authority (ECA) and Hub71 have opened applications for the 2026 Cohort of Anjal Z, a fello | [Link](https://longbridge.com/en/news/276314981.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.